CA-074

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCA-074
Drug Alias NameCA-074
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCathepsin B inhibitors
TargetsCathepsin B
Therapy Area/IndicationsGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHenry Ford Health System
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHenry Ford Health System
Active IndicationsN/A
Inactive IndicationsGlioma

Other Information

ATC CodeN/A
Related LinksN/A